Insulin-like growth factor 1 (IGF1) and its active peptide (1-3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms.
AuthorsCorvin, Aiden P
Morris, Derek W
AffiliationNeuropsychiatric Genetics Research Group, Department of Psychiatry, Trinity College Dublin, St. James Hospital, Dublin 8, Ireland.
Insulin-Like Growth Factor I
Mitogen-Activated Protein Kinases
Primary Cell Culture
Receptor, IGF Type 1
MetadataShow full item record
CitationInsulin-like growth factor 1 (IGF1) and its active peptide (1-3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms. 2012, 520 (1):51-6 Neurosci. Lett.
AbstractInsulin-like growth factor-1 (IGF1) and its active peptide (1-3)IGF1 modulate brain growth and plasticity and are candidate molecules for treatment of brain disorders. IGF1 N-terminal portion is naturally cleaved to generate the tri-peptide (1-3)IGF1 (glycine-praline-glutamate). IGF1 and (1-3)IGF have been proposed as treatment for neuropathologies, yet their effect on nerve cells has not been directly compared. In this study we examine the effects of IGF1 and (1-3)IGF1 in primary cortical cultures and measure the expression levels of markers for intracellular pathways and synaptic function. We find that both treatments activate the IGF1 receptor and enhance the expression of synaptic markers, however, they activate different intracellular pathways. Furthermore, (1-3)IGF1 administration increases the expression of endogenous IGF1, suggesting a direct interaction between the two molecules. The results show that the two molecules increase the expression of synaptic proteins through activating different cellular mechanisms.
- Initiation factor 2B activity is regulated by protein phosphatase 1, which is activated by the mitogen-activated protein kinase-dependent pathway in insulin-like growth factor 1-stimulated neuronal cells.
- Authors: Quevedo C, Salinas M, Alcázar A
- Issue date: 2003 May 9
- A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
- Authors: Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D
- Issue date: 2003 Feb 1
- Exercise modulates insulin-like growth factor 1-dependent and -independent effects on adult hippocampal neurogenesis and behaviour.
- Authors: Llorens-Martín M, Torres-Alemán I, Trejo JL
- Issue date: 2010 Jun
- Intermittent high glucose concentrations reduce neuronal precursor survival by altering the IGF system: the involvement of the neuroprotective factor DHCR24 (Seladin-1).
- Authors: Giannini S, Benvenuti S, Luciani P, Manuelli C, Cellai I, Deledda C, Pezzatini A, Vannelli GB, Maneschi E, Rotella CM, Serio M, Peri A
- Issue date: 2008 Sep
- Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex.
- Authors: Cheng CM, Cohen M, Wang J, Bondy CA
- Issue date: 2001 Apr